VistaPath raises $4M in financing

2018 08 28 18 59 9066 Artificial Intelligence Ai 400

Artificial intelligence (AI)-based pathology processing platform developer VistaPath has secured $4 million in seed funding to modernize pathology labs with artificial intelligence and computer vision.

VistaPath's Sentinel platform aims to deliver a range of solutions for lab processes. The company's first application, which was released in 2021, is a tissue-grossing platform that automates receiving, assessing, and processing tissue samples.

It uses a high-quality video system combined with AI to assess specimens and create a gross report 93% faster than human technicians with 43% more accuracy, the firm said.

The company said it anticipates releasing additional applications later this year.

Page 1 of 15
Next Page